Marinus Pharmaceuticals Inc

Marinus Pharmaceuticals Inc is a pharmaceutical company dedicated to developing and commercialising innovative therapeutics. Its aim is to address significant unmet medical needs in rare neurological disorders. The company operates globally, bringing its treatments to patients worldwide. Operating within the biotechnology and pharmaceutical sector, Marinus Pharmaceuticals Inc specialises in developing compounds for central nervous system (CNS) disorders. Their research focuses on creating new treatments designed to improve the quality of life for patients with debilitating conditions. Keep up to date on the latest share price by adding MRNS stock to your eToro watchlist. This content was generated by artificial intelligence. We cannot guarantee the accuracy, completeness, or timeliness of the information provided.